MNBTD
LFCR icon

Moody National Bank Trust Division’s Lifecore Biomedical LFCR Stock Holding History

Moody National Bank Trust Division’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-291
Closed -$4K – 696
2019
Q1 		$4K Buy
+291
New +$3.55K ﹤0.01% 1063

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Moody National Bank Trust Division's LFCR Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Lifecore Biomedical (LFCR) in Q2 2019, closing a stake of 291 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in LFCR in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Lifecore Biomedical position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 291 Lifecore Biomedical shares in Q2 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in Lifecore Biomedical in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Lifecore Biomedical position peaked at $4K in Q1 2019.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.